← Back to Search

Dietary Supplement

bright light melatonin for Genetics

N/A
Waitlist Available
Led By Frank AJL Scheer, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 of the three in-lab protocols
Awards & highlights

Study Summary

This trial will test the effects of melatonin and a gene variation on regulating blood sugar, both in a laboratory and on real people.

Eligible Conditions
  • Genetics
  • Melatonin
  • Circadian Rhythm
  • Diabetes
  • Photophobia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 of the three in-lab protocols
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 of the three in-lab protocols for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in glucose tolerance
Secondary outcome measures
change in first-phase insulin release

Trial Design

3Treatment groups
Experimental Treatment
Group I: dim lightExperimental Treatment1 Intervention
Group II: bright light placeboExperimental Treatment2 Interventions
Group III: bright light melatoninExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
placebo
2010
Completed Phase 4
~6580
melatonin
2013
Completed Phase 3
~2260

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,615 Previous Clinical Trials
11,470,806 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,568 Total Patients Enrolled
Frank AJL Scheer, PhDPrincipal Investigator - Brigham and Women's Hospital
Brigham and Women's Hospital
4 Previous Clinical Trials
427 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2
Frank AJL Scheer, PhD 2018. "Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03464084.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top